Global AIDS Rapid Test Kit Market Research Report 2022

Due to the COVID-19 pandemic, the global AIDS Rapid Test Kit market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe AIDS Rapid Test Kit market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe AIDS Rapid Test Kit landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
Blood Test accounting for % of the AIDS Rapid Test Kit global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospital segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2028.
The global major manufacturers of AIDS Rapid Test Kit include Abbott, AccuBioTech, Chembio Diagnostic Systems, Inc, Orasure Technologies, Standard Diagnostics, Autobio Diagnostics Co., LTD, Turklab Tibbi Malzemeler San. Tic. A.S and Maccura Biotechnology Co., Ltd, etc. In terms of revenue, the global 3 largest players have a % market share of AIDS Rapid Test Kit in 2021.
This report focuses on AIDS Rapid Test Kit volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall AIDS Rapid Test Kit market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.
Global AIDS Rapid Test Kit Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Blood Test
Saliva Test
Segment by Application
Hospital
Medical Station
Pharmacy
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Abbott
AccuBioTech
Chembio Diagnostic Systems, Inc
Orasure Technologies
Standard Diagnostics
Autobio Diagnostics Co., LTD
Turklab Tibbi Malzemeler San. Tic. A.S
Maccura Biotechnology Co., Ltd